axicabtagene ciloleucel
daiichi sankyo,gilead
['axi-cel', ' sun ', 'lymphoma']
#ash22
abstract 165
ulrike gerdemann et al. cd19-car t-cell therapy with axi-cel is safe in patients with primary or secondary cns lymphoma. cns car t cells are predominantly cd4+, with interferon signature signature conversion happens upon entry into the csf 
Hematologist at Saint Antoine Hospital, Paris, France @Sorbonne_Univ_ @APHP. @JACIE_EBMT National Representative. #BMTsm #LYMsm #CARTcell #CardioOnc #QoL